Collagen type VI regulates TGF-β bioavailability in skeletal muscle in mice
Journal of Clinical Investigation · 01.05.2025 · 135 (9)
DOI: 10.1172/jci173354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.05.2025. Verfasst von Payam Mohassel und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Neurological Disorders and Stroke, Neuromuscular and Neurogenetic Disorders of Childhood Section, NIH, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Collagen Type VI, Muscle, Skeletal, Transforming Growth Factor beta, Muscular Dystrophies. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIAMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Collagen VI–related disorders ( COL6 -RDs) are a group of rare muscular dystrophies caused by pathogenic variants in collagen VI genes ( COL6A1 , COL6A2 , and COL6A3 ). Collagen type VI is a heterotrimeric, microfibrillar component of the muscle extracellular matrix (ECM), predominantly secreted by resident fibroadipogenic precursor cells in skeletal muscle. The absence or mislocalization of collagen VI in the ECM underlies the noncell-autonomous dysfunction and dystrophic changes in skeletal muscle with a yet elusive direct mechanistic link between the ECM and myofiber dysfunction. Here, we conducted a comprehensive natural history and outcome study in a mouse model of COL6 -RDs ( Col6a2 –/– mice) using standardized (TREAT-NMD) functional, histological, and physiological parameters. Notably, we identify a conspicuous dysregulation of the TGF-β pathway early in the disease process and propose that the collagen VI–deficient matrix is not capable of regulating the dynamic TGF-β bioavailability both at baseline and in response to muscle injury. Thus, we propose a new mechanism for pathogenesis of the disease that links the ECM regulation of TGF-β with downstream skeletal muscle abnormalities, paving the way for the development and validation of therapeutics that target this pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Neurological Disorders and Stroke, Neuromuscular and Neurogenetic Disorders of Childhood Section, NIH, Bethesda, Maryland, USA.
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Bioinformatics Section, Intramural Information Technology & Bioinformatics Program, National Institute of Neurological Disorders and Stroke, and.
- Clinical Trials Unit, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA.
- Department of Ecology and Evolutionary Biology, University of California, Irvine, Irvine, California, USA.
- Department of Ecology and Evolutionary Biology, Brown University, Providence, Rhode Island, USA.
Förderung
- NINDS NIH HHS
- NIAMS NIH HHS
- NIH HHS
- Intramural NIH HHS
- National Institutes of Health
- NIH Office of the Director
- University of Pennsylvania Orphan Disease Center
Zitieren
APA
Mohassel, P., Hearn, H., Rooney, J., Zou, Y., Johnson, K., Norato, G., Nalls, M. A., Yun, P., Ogata, T., Silverstein, S., Sleboda, D. A., Roberts, T. J., Rifkin, D. B., & Bönnemann, C. G. (2025). Collagen type VI regulates TGF-β bioavailability in skeletal muscle in mice. Journal of Clinical Investigation, 135(9). https://doi.org/10.1172/jci173354
Vancouver
Mohassel P, Hearn H, Rooney J, Zou Y, Johnson K, Norato G, et al. Collagen type VI regulates TGF-β bioavailability in skeletal muscle in mice. Journal of Clinical Investigation. 2025;135(9). doi:10.1172/jci173354
BibTeX
@article{Mohassel2025,
author = {Mohassel, Payam and Hearn, Hailey and Rooney, Jachinta and Zou, Yaqun and Johnson, Kory and Norato, Gina and Nalls, Matthew A and Yun, Pomi and Ogata, Tracy and Silverstein, Sarah and Sleboda, David A and Roberts, Thomas J and Rifkin, Daniel B and Bönnemann, Carsten G},
title = {Collagen type VI regulates TGF-β bioavailability in skeletal muscle in mice},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {9},
doi = {10.1172/jci173354}
}
EUVIMED